One-Time gene shot aims to stop bleeding in hemophilia a

NCT ID NCT06833983

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a single-dose gene therapy called GS1191-0445 in 50 Chinese men with hemophilia A. The treatment uses a harmless virus to deliver a working gene to the liver, helping the body produce its own clotting factor. The goal is to reduce bleeding episodes and the need for regular factor infusions. Participants will be monitored for safety and effectiveness over one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Anhui Provincial Hospital

    NOT_YET_RECRUITING

    Hefei, Anhui, 230001, China

  • Central Hospital Affiliated to Shandong First Medical University

    RECRUITING

    Jinan, Shandong, 250013, China

  • First Hospital of Lanzhou University

    NOT_YET_RECRUITING

    Lanzhou, Gansu, 730099, China

  • Henan Cancer Hospital

    NOT_YET_RECRUITING

    Zhengzhou, Henan, 450003, China

  • Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College

    RECRUITING

    Tianjin, Tianjin Municipality, 300020, China

  • Jiangxi Provincial People's Hospital

    NOT_YET_RECRUITING

    Nanchang, Jiangxi, 344001, China

  • Nanfang Hospital Southern Medical University

    NOT_YET_RECRUITING

    Guangzhou, Guangdong, 510515, China

  • Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School

    NOT_YET_RECRUITING

    Nanjing, Jiangsu, 210000, China

  • North China University of Science and Technology Affiliated Hospital

    NOT_YET_RECRUITING

    Tangshan, Hebei, 063000, China

  • Peking Union Medical College Hospital

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, 100005, China

  • The second Affiliated Hospital of Kunming Medical University

    NOT_YET_RECRUITING

    Kunming, Yunnan, 650101, China

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    NOT_YET_RECRUITING

    Wuhan, Hubei, 430022, China

  • Xiangya Hospital of Central South University

    NOT_YET_RECRUITING

    Changsha, Hunan, 410028, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.